FRANCESCA KRANZ: Open Payments
NPI 1245001015 · LONE TREE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 24 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $472 · 2025 $818
Food & beverage: $628Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $264 |
| Dendreon Pharmaceuticals LLC | 2 | $157 |
| Sumitomo Pharma America, Inc. | 5 | $123 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| PFIZER INC. | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
| 180 Medical, Inc. | 1 | $29 |
| Antares Pharma, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $21 |
| ACCORD HEALTHCARE, INC. | 1 | $20 |
Products named: ERLEADA, PROVENGE, ORGOVYX, Xtandi, RYBREVANT, KEYTRUDA, GEMTESA, LUPRON DEPOT.
Industry payments across CO — which companies pay providers there.
